A pulmonary rehabilitation program reduces hospitalizations in chronic obstructive pulmonary disease patients: A cost-effectiveness study
Autor: | Maria Elena Toubes-Navarro, Francisco Gude-Sampedro, José Manuel Álvarez-Dobaño, Francisco Reyes-Santias, Carlos Rábade-Castedo, Carlota Rodríguez-García, Óscar Lado-Baleato, Raquel Lago-Fidalgo, Noelia Sánchez-Martínez, Jorge Ricoy-Gabaldón, Ana Casal-Mouriño, Romina Abelleira-Paris, Vanessa Riveiro-Blanco, Carlos Zamarrón-Sanz, Nuria Rodríguez-Núñez, Adriana Lama-López, Lucía Ferreiro-Fernández, Luis Valdés-Cuadrado |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2023 |
Předmět: | |
Zdroj: | Annals of Thoracic Medicine, Vol 18, Iss 4, Pp 190-198 (2023) |
Druh dokumentu: | article |
ISSN: | 1817-1737 1998-3557 |
DOI: | 10.4103/atm.atm_70_23 |
Popis: | BACKGROUND: Although pulmonary rehabilitation (PR) is recommended in patients with chronic obstructive pulmonary disease (COPD), there is a scarcity of data demonstrating the cost-effectiveness and effectiveness of PR in reducing exacerbations. METHODS: A quasi-experimental study in 200 patients with COPD was conducted to determine the number of exacerbations 1 year before and after their participation in a PR program. Quality of life was measured using the COPD assessment test and EuroQol-5D. The costs of the program and exacerbations were assessed the year before and after participation in the PR program. The incremental cost-effectiveness ratio (ICER) was estimated in terms of quality-adjusted life years (QALYs). RESULTS: The number of admissions, length of hospital stay, and admissions to the emergency department decreased after participation in the PR program by 48.2%, 46.6%, and 42.5%, respectively (P < 0.001 for all). Results on quality of life tests improved significantly (P < 0.001 for the two tests). The cost of PR per patient and the cost of pre-PR and post-PR exacerbations were €1867.7 and €7895.2 and €4201.9, respectively. The PR resulted in a cost saving of €1826 (total, €365,200) per patient/year, and the gain in QALYs was+0.107. ICER was −€17,056. The total cost was |
Databáze: | Directory of Open Access Journals |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |